RMMPF.US RAMM Pharma Corp.

- USD
Market cap
-
P/E
-
P/B
0.18x
ROE
-68.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2026.

Is RMMPF.US undervalued?

Graham number

The Graham number of RAMM Pharma Corp. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

RAMM Pharma Corp. fundamental analysis

No fundamental analysis for RAMM Pharma Corp. yet.

RAMM Pharma Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About RAMM Pharma Corp.

RAMM Pharma Corp., together with its subsidiaries, operates in the pharmaceutical and medical product business in Uruguay and Poland. The company offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products. It also engages in the resale of medical supplies products; and the sale of medical devices and consumables. The company was formerly known as MTC …

Full company profile